EQT to Acquire Corza Medical's TachoSil® Biosurgery Business for Growth in Surgical Solutions#Sweden#EQT#Stockholm#Corza_Medical#TachoSil
EQT to Acquire Corza Medical's TachoSil® Biosurgery Business for Growth in Surgical Solutions
EQT is set to acquire Corza Biosurgery, known for TachoSil®, enhancing surgical outcomes. This transaction aims to drive growth and innovation in the biosurgery sector.
third-news.com
July 7, 2026 at 7:01 AM
EQT to Acquire Corza Medical's TachoSil® Biosurgery Business for Growth in Surgical Solutions#Sweden#EQT#Stockholm#Corza_Medical#TachoSil
The EU has approved a Luxembourg firm’s acquisition of a surgical bleeding solutions unit, concluding it poses no threat to competition.
EU clears biosurgery merger, says competition concerns are unfounded
www.brusselstimes.com
September 23, 2026 at 8:32 PM
The EU has approved a Luxembourg firm’s acquisition of a surgical bleeding solutions unit, concluding it poses no threat to competition.
US Biosurgery Market Data 2035 - USA Healthcare Systems www.marketresearchfuture.com/reports/us-b...
US Biosurgery Market Data 2035 - USA Healthcare Systems
US Biosurgery Market share register 2500 USD Million in 2024, projected to grow 5.27 % CAGR to reach USD Million 4400 during the forecast period 2025 - 2035.
www.marketresearchfuture.com
December 24, 2025 at 7:26 AM
US Biosurgery Market Data 2035 - USA Healthcare Systems www.marketresearchfuture.com/reports/us-b...
⚕️ Enhancing surgical outcomes with innovative tools 🇮🇹 #Surgery #MedTech 🌿
www.marketresearchfuture.com/reports/ital...
www.marketresearchfuture.com/reports/ital...
Italy Biosurgery Market Size, Growth Report 2035
Italy Biosurgery Market Industry is expected to grow from 346.5(USD Million) in 2024 to 900 (USD Million) by 2035. The Italy Biosurgery Market CAGR (growth rate) is expected to be around 9.065% during...
www.marketresearchfuture.com
July 1, 2025 at 12:29 PM
⚕️ Enhancing surgical outcomes with innovative tools 🇮🇹 #Surgery #MedTech 🌿
www.marketresearchfuture.com/reports/ital...
www.marketresearchfuture.com/reports/ital...
Peer-reviewed 411-patient study reports low infection rates with MyriadTM in complex soft tissue reconstruction
Interim MASTRR Registry analysis represents, to Aroa's knowledge, the largest published prospective bioscaffold analysis in in-patient soft tissue reconstruction AUCKLAND, New Zealand,…
Interim MASTRR Registry analysis represents, to Aroa's knowledge, the largest published prospective bioscaffold analysis in in-patient soft tissue reconstruction AUCKLAND, New Zealand,…
Peer-reviewed 411-patient study reports low infection rates with MyriadTM in complex soft tissue reconstruction
Interim MASTRR Registry analysis represents, to Aroa's knowledge, the largest published prospective bioscaffold analysis in in-patient soft tissue reconstruction AUCKLAND, New Zealand, Sept. 6, 2026 /PRNewswire/ -- Aroa Biosurgery Limited (ASX: ARX), a soft tissue regeneration company,...
news-area.com
September 7, 2026 at 12:58 PM
Peer-reviewed 411-patient study reports low infection rates with MyriadTM in complex soft tissue reconstruction
Interim MASTRR Registry analysis represents, to Aroa's knowledge, the largest published prospective bioscaffold analysis in in-patient soft tissue reconstruction AUCKLAND, New Zealand,…
Interim MASTRR Registry analysis represents, to Aroa's knowledge, the largest published prospective bioscaffold analysis in in-patient soft tissue reconstruction AUCKLAND, New Zealand,…
📢 Biosurgery is #hiring a Associate Director, Global Health Economics Market Access!
🌎 6041
🔗 http://jbs.ink/6n8FmUNWctHw
#jobalert #jobsearch #familyofficejobs #machinelearning #marketing
🌎 6041
🔗 http://jbs.ink/6n8FmUNWctHw
#jobalert #jobsearch #familyofficejobs #machinelearning #marketing
August 17, 2026 at 5:15 AM
📢 Biosurgery is #hiring a Associate Director, Global Health Economics Market Access!
🌎 6041
🔗 http://jbs.ink/6n8FmUNWctHw
#jobalert #jobsearch #familyofficejobs #machinelearning #marketing
🌎 6041
🔗 http://jbs.ink/6n8FmUNWctHw
#jobalert #jobsearch #familyofficejobs #machinelearning #marketing
Aroa Biosurgery Strengthens U.S. Commercial Team with New Appointments#New_Zealand#Auckland#Aroa_Biosurgery#Michael_Lynskey#Mike_Falcon
Aroa Biosurgery Strengthens U.S. Commercial Team with New Appointments
Aroa Biosurgery Limited has announced the appointments of Michael Lynskey and Mike Falcon to its U.S. team, enhancing its commercial strategy.
third-news.com
July 28, 2026 at 5:12 AM
Aroa Biosurgery Strengthens U.S. Commercial Team with New Appointments#New_Zealand#Auckland#Aroa_Biosurgery#Michael_Lynskey#Mike_Falcon
Feed: "Stockhead"
By: Stockhead TV on Tuesday, July 14, 2026
By: Stockhead TV on Tuesday, July 14, 2026
Long Shortz with Aroa Biosurgery: Symphony remains well positioned under CMS proposal
The latest US reimbursement updates for Symphony and why the proposed CMS changes are significant for the outpatient wound care market.
stockhead.com.au
July 14, 2026 at 11:20 PM
Feed: "Stockhead"
By: Stockhead TV on Tuesday, July 14, 2026
By: Stockhead TV on Tuesday, July 14, 2026
Biosurgery Market Trends | Industry Analysis & Insights 2035 | WiseGuyReports www.wiseguyreports.com/reports/bio-...
www.wiseguyreports.com
July 14, 2026 at 9:21 AM
Biosurgery Market Trends | Industry Analysis & Insights 2035 | WiseGuyReports www.wiseguyreports.com/reports/bio-...
Latham & Watkins Advises EQT in Acquisition of TachoSil® Biosurgery Business from Corza Medical
EQT has announced that EQT X has agreed to acquire Corza Biosurgery from Corza Medical, comprising... The post Latham & Watkins Advises EQT in Acquisition of TachoSil® Biosurgery Business from Corza…
EQT has announced that EQT X has agreed to acquire Corza Biosurgery from Corza Medical, comprising... The post Latham & Watkins Advises EQT in Acquisition of TachoSil® Biosurgery Business from Corza…
Latham & Watkins Advises EQT in Acquisition of TachoSil® Biosurgery Business from Corza Medical
EQT has announced that EQT X has agreed to acquire Corza Biosurgery from Corza Medical, comprising... The post Latham & Watkins Advises EQT in Acquisition of TachoSil® Biosurgery Business from Corza Medical appeared first on Legal Desire Media and Insights .
news-area.com
July 8, 2026 at 9:29 PM
Latham & Watkins Advises EQT in Acquisition of TachoSil® Biosurgery Business from Corza Medical
EQT has announced that EQT X has agreed to acquire Corza Biosurgery from Corza Medical, comprising... The post Latham & Watkins Advises EQT in Acquisition of TachoSil® Biosurgery Business from Corza…
EQT has announced that EQT X has agreed to acquire Corza Biosurgery from Corza Medical, comprising... The post Latham & Watkins Advises EQT in Acquisition of TachoSil® Biosurgery Business from Corza…
GTCR Completes Sale of Corza Medical's Biosurgery Unit to EQT for Strategic Growth#United_States#Chicago#GTCR#Corza_Medical#TachoSil
GTCR Completes Sale of Corza Medical's Biosurgery Unit to EQT for Strategic Growth
GTCR has signed an agreement to sell Corza Medical's Biosurgery unit to EQT, allowing Corza to focus on other surgical business sectors while enhancing growth strategies.
third-news.com
July 7, 2026 at 6:08 AM
GTCR Completes Sale of Corza Medical's Biosurgery Unit to EQT for Strategic Growth#United_States#Chicago#GTCR#Corza_Medical#TachoSil
India Biosurgery Market Size & Forecast, 2035 | MRFR www.marketresearchfuture.com/reports/indi...
India Biosurgery Market Size & Forecast, 2035 | MRFR
India Biosurgery Market share register 577.50 USD Million in 2024, projected to grow 5.12 % CAGR to reach USD Million 1000.20 during the forecast period 2025 - 2035.
www.marketresearchfuture.com
January 29, 2026 at 6:26 PM
India Biosurgery Market Size & Forecast, 2035 | MRFR www.marketresearchfuture.com/reports/indi...
India Biosurgery Market Size & Forecast, 2035 | MRFR www.marketresearchfuture.com/reports/indi...
India Biosurgery Market Size & Forecast, 2035 | MRFR
India Biosurgery Market share register 577.50 USD Million in 2024, projected to grow 5.12 % CAGR to reach USD Million 1000.20 during the forecast period 2025 - 2035.
www.marketresearchfuture.com
December 10, 2025 at 12:17 PM
India Biosurgery Market Size & Forecast, 2035 | MRFR www.marketresearchfuture.com/reports/indi...
RN Biosurgery Clinical Educator-Boston - Parsippany, New Jersey, United States of America Job educativ.net/jobs/job/60964...
June 23, 2026 at 9:24 PM
RN Biosurgery Clinical Educator-Boston - Parsippany, New Jersey, United States of America Job educativ.net/jobs/job/60964...
Biosurgery Clinical Nurse Educator Winston-Salem - Parsippany, New Jersey, United States of America Job educativ.net/jobs/job/60306...
June 9, 2026 at 11:13 PM
Biosurgery Clinical Nurse Educator Winston-Salem - Parsippany, New Jersey, United States of America Job educativ.net/jobs/job/60306...
📢 Host Tylah Tully sits down with Aroa Biosurgery (ASX:ARX) founder and CEO Brian Ward to unpack the company’s breakout FY26 results, including record revenue growth, strong EBITDA performance and accelerating momentum from its Myriad product line.
ARX delivers breakout FY26 results
www.theaustralian.com.au
May 27, 2026 at 4:33 PM
📢 Host Tylah Tully sits down with Aroa Biosurgery (ASX:ARX) founder and CEO Brian Ward to unpack the company’s breakout FY26 results, including record revenue growth, strong EBITDA performance and accelerating momentum from its Myriad product line.
📢 Special Report: Soft-tissue repair company Aroa Biosurgery has delivered a strong FY26 result, beating revenue and earnings guidance as rapid growth from its flagship Myriad wound care portfolio continues to do the heavy lifting.
Aroa beats FY26 guidance
www.theaustralian.com.au
May 26, 2026 at 7:23 PM
📢 Special Report: Soft-tissue repair company Aroa Biosurgery has delivered a strong FY26 result, beating revenue and earnings guidance as rapid growth from its flagship Myriad wound care portfolio continues to do the heavy lifting.